So-Young International Inc.

NASDAQ:SY

Medical - Healthcare Information Services

Healthcare
$1.83 -5.83%

-$0.09 today

Market cap
$239.36M
Beta
1.98
P/E (TTM)
-5.0
EPS (TTM)
-$1.95
52W Low $1.00High $6.28

Volume 0.46M

Average 0.63M

SY Net Income

Bottom-line profit after all expenses, interest, and taxes.

So-Young International Inc.NASDAQ: SY

Net Income · Q1 FY2026 · quarter ended Mar 2026

Net income remains negative

Q1 FY2026 net income was -CN¥48.88M, compared with -CN¥33.14M a year earlier. Trailing-twelve-month net income was -CN¥256.54M.

Context

  • Net income amounted to 15.9% of revenue in FY2025, down 24.3 pp from a year earlier.
  • Net income increased in 2 of the last 3 fiscal years.

What to watch

Whether net income reaches the consensus estimate from 2 analysts of -CN¥206.31M (+12.5%) for the fiscal year ending Dec 2026, a slowdown from the +60.0% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-CN¥48.88M+54.5% QoQ
Last fiscal yearDec 2025
-CN¥235.7M+60.0% YoY
LTMMar 2026
-CN¥256.54M+57.3% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-47.5%-117.7%-70.2 pp
1 year+60.0%+12.5%-47.6 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

CNY · from the income statement

Latest · FY2025
(235.7M) CNY
Year-over-year change
+60.0%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How SY compares with its peers on the latest reported figures

  • Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +57.3% is the 3rd highest of 11, against a peer median of -6.9%.
  • Net income amounts to 15.5% of revenue for SY, versus a peer median of 88.8%.
SY Competitors
Net Income for SY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
OMEROmeros CorporationLTM Mar 2026$86.17M USD+156.3%—871.0%
LXRXLexicon Pharmaceuticals, Inc.LTM Mar 2026-$26.09M USD+85.3%—37.5%
SLPSimulations Plus, Inc.LTM Feb 2026-$62.79M USD-964.8%—78.0%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026-$80.94M USD-22.3%—99.7%
VREXVarex Imaging CorporationLTM Apr 2026-$82.7M USD-96.9%—9.6%
LABStandard BioTools Inc.LTM Mar 2026-$94.08M USD+29.1%—109.1%
SNDASonida Senior Living, Inc.LTM Mar 2026-$99.48M USD-139.1%—24.2%
ADCTADC Therapeutics S.A.LTM Mar 2026-$136.99M USD+8.6%—173.0%
CGEMCullinan Therapeutics, Inc.LTM Mar 2026-$221.04M USD-23.7%——
NMRANeumora Therapeutics, Inc. Common StockLTM Mar 2026-$222.39M USD+13.8%——
SYSo-Young International Inc.LTM Mar 2026-CN¥256.54M CNY+57.3%—15.5%
Peer median (excluding SY) —-6.9%—88.8%

Competitors are the stored peer set for SY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CNY
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.69B1.26B1.5B1.47B1.48B
Cost of Revenue327.89M393.29M544.34M567.59M774.04M
Gross Profit1.36B864.58M953.69M899.11M707.86M
Gross Margin80.6%68.7%63.7%61.3%47.8%
Research & Development286.57M235.09M203.52M165.03M133.31M
Selling, General & Admin1.04B732.3M811.22M818.57M833.76M
Operating Expenses1.4B967.39M1.01B1.52B967.07M
Depreciation & Amortization30.08M47.09M46.09M46.09M57.21M
EBITDA63.39M(39.99M)53.96M(38.39M)(182.19M)
EBITDA Margin3.7%-3.2%3.6%-2.6%-12.3%
Operating Income(32.57M)(102.81M)(61.05M)(624.49M)(259.21M)
Operating Margin-1.9%-8.2%-4.1%-42.6%-17.5%
Interest Income19.33M28.88M48.84M46.51M24.6M
Interest Expense00000
Other Income / Expenses16.17M15.73M68.92M36.41M19.8M
Income Before Tax(16.41M)(87.07M)7.87M(588.09M)(239.4M)
Pre-Tax Margin-1.0%-6.9%0.5%-40.1%-16.2%
Income Tax Expense21.23M(20.97M)(18.08M)(905K)(774.31K)
Net Income(8.37M)(65.55M)21.28M(589.53M)(235.7M)
Net Margin-0.5%-5.2%1.4%-40.2%-15.9%
EPS (Basic)(0.06)(0.48)0.16(4.40)(1.78)
EPS (Diluted)(0.06)(0.48)0.16(4.39)(1.78)
Weighted Avg Shares138.04M138.04M133.19M134.09M131.59M
Weighted Avg Shares (Diluted)138.04M138.04M131.91M134.16M131.59M

So-Young International Inc.

NASDAQ:SY

Intrinsic Alpha fair value

Locked

Current Price

$1.83

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.